Showing results (191-200 of 336) with videos related to
Sort By:
Pageof 34
Open Forum Infectious Diseases|May 9, 2017
A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral TherapyMeagan P O'Brien, Peter W Hunt, Douglas W Kitch, et al.Annals of the Rheumatic Diseases|August 21, 2016
Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activityCarolyne K Smith, Nickie L Seto, Anuradha Vivekanandan-Giri, et al.BMJ Open|September 26, 2023
Early Detection and Progression of Subclinical Atherosclerosis in Psoriasis (EDSAP): protocol for an observational, single-centre, prospective cohort studyCarlota Abbad-Jaime de Aragón, Emilio Berna-Rico, María Asunción Ballester-Martinez, et al.Ebiomedicine|October 16, 2016
Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir AlafenamideNicholas T Funderburg, Grace A McComsey, Manjusha Kulkarni, et al.Journal of Leukocyte Biology|August 9, 2018
Cenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expressionMichelle L D'Antoni, Brooks I Mitchell, Sara McCurdy, et al.Lipids in Health and Disease|April 27, 2023
Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: a prospective observational studyAlexander V Sorokin, Nidhi Patel, Haiou Li, et al.The Journal of Investigative Dermatology|December 4, 2018
Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 WeeksEsther von Stebut, Kristian Reich, Diamant Thaçi, et al.American Journal of Cardiovascular Disease|November 14, 2013
A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot studyShawn Rose, Nikhil H Sheth, Joshua F Baker, et al.Plos One|December 25, 2013
Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabineNicholas T Funderburg, Adriana Andrade, Ellen S Chan, et al.The Journal of Clinical Endocrinology and Metabolism|March 22, 2007
Innate immunity modulates adipokines in humansPaul D Anderson, Nehal N Mehta, Megan L Wolfe, et al.Pageof 34